Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

656 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Crovalimab treatment in patients with paroxysmal nocturnal haemoglobinuria: Long-term results from the phase I/II COMPOSER trial.
Röth A, Ichikawa S, Ito Y, Kim JS, Nagy Z, Obara N, Panse J, Schrezenmeier H, Sica S, Soret J, Usuki K, Yoon SS, Balachandran N, Buri M, Lundberg P, Patel H, Shinomiya K, Sostelly A, Nishimura JI. Röth A, et al. Among authors: lundberg p. Eur J Haematol. 2023 Aug;111(2):300-310. doi: 10.1111/ejh.14011. Epub 2023 Jun 15. Eur J Haematol. 2023. PMID: 37321625 Clinical Trial.
Erythropoietin receptor mutation--a rush of blood to the head?
Holbro A, Skoda R, Lundberg P, Passweg J, Buser A, Lehmann T. Holbro A, et al. Among authors: lundberg p. Ann Hematol. 2015 Jul;94(7):1229-31. doi: 10.1007/s00277-015-2346-7. Epub 2015 Mar 14. Ann Hematol. 2015. PMID: 25772631 No abstract available.
Effects of lenalidomide on the bone marrow microenvironment in acute myeloid leukemia: Translational analysis of the HOVON103 AML/SAKK30/10 Swiss trial cohort.
Brune MM, Stüssi G, Lundberg P, Vela V, Heim D, Manz MG, Haralambieva E, Pabst T, Banz Y, Bargetzi M, Grobholz R, Fehr M, Cogliatti S, Ossenkoppele GJ, Löwenberg B, Rudolf CB, Li Q, Passweg J, Mazzuchelli L, Medinger M, Tzankov A; Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK). Brune MM, et al. Among authors: lundberg p. Ann Hematol. 2021 May;100(5):1169-1179. doi: 10.1007/s00277-021-04467-2. Epub 2021 Mar 2. Ann Hematol. 2021. PMID: 33704530 Free PMC article. Clinical Trial.
Clonogenic versus morphogenic mutations in myeloid neoplasms: chronologic observations in a U2AF1, TET2, CSF3R and JAK2 'co-mutated' myeloproliferative neoplasm suggest a hierarchical order of mutations and potential predictive value for kinase inhibitor treatment response.
Gerlach MM, Lundberg P, Halter J, Arranto C, Wenzel F, Dirnhofer S, Tzankov A. Gerlach MM, et al. Among authors: lundberg p. Leuk Lymphoma. 2018 Aug;59(8):1994-1997. doi: 10.1080/10428194.2017.1406087. Epub 2017 Dec 3. Leuk Lymphoma. 2018. PMID: 29199511 No abstract available.
Differential effects of hydroxyurea and INC424 on mutant allele burden and myeloproliferative phenotype in a JAK2-V617F polycythemia vera mouse model.
Kubovcakova L, Lundberg P, Grisouard J, Hao-Shen H, Romanet V, Andraos R, Murakami M, Dirnhofer S, Wagner KU, Radimerski T, Skoda RC. Kubovcakova L, et al. Among authors: lundberg p. Blood. 2013 Feb 14;121(7):1188-99. doi: 10.1182/blood-2012-03-415646. Epub 2012 Dec 20. Blood. 2013. PMID: 23264594 Free article.
Hematology Testing in Mice.
Lundberg P, Skoda R. Lundberg P, et al. Curr Protoc Mouse Biol. 2011 Sep 1;1(3):323-46. doi: 10.1002/9780470942390.mo110088. Curr Protoc Mouse Biol. 2011. PMID: 26069057
656 results